Third Assisi Workshop on Biomarkers in the early diagnosis ... · 16:45 – 17:00 Coffee break...

12
Third Assisi Workshop on Biomarkers in the early diagnosis of neurodegenerative disorders Congress Centre Roseo Hotel Assisi Assisi, 21-23 May 2015 Organized by Paolo Calabresi and Lucilla Parnetti Clinica Neurologica, Università degli Studi di Perugia

Transcript of Third Assisi Workshop on Biomarkers in the early diagnosis ... · 16:45 – 17:00 Coffee break...

Page 1: Third Assisi Workshop on Biomarkers in the early diagnosis ... · 16:45 – 17:00 Coffee break 17:00 – 17:45 Magistral Lecture Introduced by Markus Otto Kaj Blennow “CSF biomarkers

Third Assisi Workshop onBiomarkers in the early diagnosisof neurodegenerative disorders

Congress Centre Roseo Hotel AssisiAssisi, 21-23 May 2015

Organized by Paolo Calabresi and Lucilla Parnetti

Clinica Neurologica, Università degli Studi di Perugia

Page 2: Third Assisi Workshop on Biomarkers in the early diagnosis ... · 16:45 – 17:00 Coffee break 17:00 – 17:45 Magistral Lecture Introduced by Markus Otto Kaj Blennow “CSF biomarkers

E’ STATO RICHIESTO IL PATROCINIO DI:

SIN Società Italiana di Neurologia

SINDEM Associazione Autonoma Aderente alla SIN per le Demenze

DISMOV-SIN Associazione Italiana Disturbi del Movimento e Malattia di Parkinson

LIMPE Lega Italiana per la lotta contro la Malattia di Parkinson, le Sindromi Extrapiramidali e le Demenze

SINS Società Italiana di Neuroscienze

UNIVERSITA’ DEGLI STUDI DI PERUGIA Scuola di Medicina REGIONE UMBRIA Assessorato alla Sanità

AZIENDA OSPEDALIERA SANTA MARIA DELLA MISERICORDIA DI PERUGIA

Page 3: Third Assisi Workshop on Biomarkers in the early diagnosis ... · 16:45 – 17:00 Coffee break 17:00 – 17:45 Magistral Lecture Introduced by Markus Otto Kaj Blennow “CSF biomarkers

FACU

LTY ANDREASSON ULF GÖTEBORG SWEDEN

BARONE PAOLO SALERNO ITALYBECCARI TOMMASO PERUGIA ITALYBEZARD ERWAN BORDEAUX FRANCEBLENNOW KAJ GÖTEBORG SWEDENBROOKS DAVID AARHUS DENMARKBRUNI AMALIA LAMEZIA TERME ITALYBURATTI EMANUELE TRIESTE ITALYCALABRESI PAOLO PERUGIA ITALYCHIASSERINI DAVIDE PERUGIA ITALYCOART ELISABETH GENT BELGIUMDECRESSAC MICKAEL NAPOLI ITALYDI FILIPPO MASSIMILIANO PERUGIA ITALYEL AGNAF OMAR MUKHTAR DOHA QATAREMILIANI CARLA PERUGIA ITALYEUSEBI PAOLO PERUGIA ITALYFORLONI GIANLUIGI MILANO ITALYGALIMBERTI DANIELA MILANO ITALYGARDONI FABRIZIO MILANO ITALYJELLINGER KURT WIEN AUSTRIAKLUENEMANN HANS WENZENBACH GERMANYLEWCZUK PIOTR ERLANGEN GERMANYOBESO JOSE MADRID SPAINOTTO MARKUS ULM GERMANYOUTEIRO TIAGO FLEMING GÖTEBORG SWEDENPADOVANI ALESSANDRO BRESCIA ITALYPARNETTI LUCILLA PERUGIA ITALYPICCONI BARBARA ROMA ITALYPISANI ANTONIO ROMA ITALYSAFTIG PAUL KIEL GERMANYSCARPINI ELIO ANGELO MILANO ITALYSCHAPIRA ANTHONY LONDON UNITED KINGDOMSTANZIONE PAOLO ROMA ITALYSTOCCHI FABRIZIO ROMA ITALYTAGLIAVINI FABRIZIO MILANO ITALYTAMBASCO NICOLA PERUGIA ITALYTOZZI ALESSANDRO PERUGIA ITALYVAN DE BERG WILMA AMSTERDAM THE NETHERLANDS

Page 4: Third Assisi Workshop on Biomarkers in the early diagnosis ... · 16:45 – 17:00 Coffee break 17:00 – 17:45 Magistral Lecture Introduced by Markus Otto Kaj Blennow “CSF biomarkers

14:30 - 15:00 Welcome addresses from Paolo Calabresi, Lucilla Parnetti and Local Authorities

15:00 – 19:30 SESSION 1: “Molecular mechanisms of oligomeropathies”

15:00 - 16:45 SESSION 1A

Chairpersons: Paolo Calabresi, Daniela Galimberti Gianluigi Forloni “The concept of oligomeropathy”

Omar El Agnaf “Alpha synuclein in PD and other neurodegenerative disorders”

Tiago Outeiro “Glycation: a bitter sweet modification in synucleinopathies”

16:45 – 17:00 Coffee break

17:00 – 17:45 Magistral Lecture Introduced by Markus Otto

Kaj Blennow “CSF biomarkers for AD - current status and future perspectives: novel biomarkers for mechanistic understanding”

17:45 - 19:30 SESSION 1B

Chairpersons: Omar El Agnaf, Gianluigi Forloni Emanuele Buratti “Use of TDP-43 for biomarker and disease-modeling analyses”

Fabrizio Tagliavini “CSF beta amyloid profiles in Alzheimer’s Disease”

Erwan Bézard “Targeting alpha-synuclein as a possible therapeutic option”

19:15 – 19:30 Discussion

20:30 Dinner

THURSDAY 21, AFTERNOON

Page 5: Third Assisi Workshop on Biomarkers in the early diagnosis ... · 16:45 – 17:00 Coffee break 17:00 – 17:45 Magistral Lecture Introduced by Markus Otto Kaj Blennow “CSF biomarkers

8:30 – 9:10 Special topic Paolo Eusebi, Els Coart “Comparing and combining biomarkers in research setting and clinical practice: statistical issues”

9:10 – 13:30 SESSION 2: “Synaptopathies”

9:10 - 10:40 SESSION 2A

Chairpersons: Piotr Lewczuk, Lucilla Parnetti Markus Otto “CSF synaptic biomarkers in frontotemporal lobar degeneration”

Ulf Andreasson “CSF biomarkers for AD - from research biomarkers to validated biomarkers: the long road of standardisation.”

Barbara Picconi “Dyskinesia as model of synaptopathy”

10:40 – 11:00 Coffee break

11:00 – 11:45 Magistral Lecture Introduced by Lucilla Parnetti Kurt Jellinger “Candidate Biomarkers in Multiple System Atrophy”

11:45 - 13:15 SESSION 2B Chairpersons: Paolo Stanzione, Nicola Tambasco

David Brooks “Imaging synaptopathies”

Massimiliano Di Filippo, Alessandro Tozzi “Inflammation and synaptopathies”

Fabrizio Gardoni “Synaptopathies and NMDA receptors subunits”

13:15 – 13:30 Discussion

13:30 – 14:30 Lunch

FRIDAY 22, MORNING

Page 6: Third Assisi Workshop on Biomarkers in the early diagnosis ... · 16:45 – 17:00 Coffee break 17:00 – 17:45 Magistral Lecture Introduced by Markus Otto Kaj Blennow “CSF biomarkers

FRIDAY 22, AFTERNOON

14:30 – 19:00 SESSION 3: “Autophagy-lysosomal pathways in neurodegenerative diseases”

14:30 – 16:15 SESSION 3A

Chairpersons: Amalia Bruni, Carla Emiliani Paul Saftig “ Lysosomes in neuronal cells: principles and pathological functions” Mickael Decressac “Cross-talk between alpha synuclein and lysosomal system in PD”

Hans Klunemann “New insights on Niemann-Pick disease”

16:15 – 16:30 Coffee break

16:30 – 17:15 Magistral Lecture Introduced by José Obeso

Anthony Schapira “Glucocerebrosidase and Parkinson disease”

17:15 – 19:00 SESSION 3B

Chairpersons: Paul Saftig, Anthony Schapira

Wilma van de Berg “Alpha-synuclein aggregation and degradation

in Parkinson’s disease”

Davide Chiasserini “Lysosomal enzymes as candidate biomarkers for neurodegenerative diseases”

Tommaso Beccari “Origin of CSF lysosomal enzymes”

19:00 - 19:15 Discussion

20:30 Dinner

Page 7: Third Assisi Workshop on Biomarkers in the early diagnosis ... · 16:45 – 17:00 Coffee break 17:00 – 17:45 Magistral Lecture Introduced by Markus Otto Kaj Blennow “CSF biomarkers

08:30 - 13:00 SESSION 4: “An update on pharmacological approaches to Alzheimer’s disease and Parkinson’s disease”

08:30 – 10:15 SESSION 4A

Chairpersons: Paolo Barone, Fabrizio Tagliavini

Piotr Lewczuk “Diagnostic role of the CSF Aß42/40 ratio in AD”

Elio Scarpini “Disease modifying therapies for Alzheimer’s disease”

Alessandro Padovani “Role of neuroimaging as selection criterion for disease modifying therapies in Alzheimer’s disease”

10:15 – 11:00 Magistral Lecture Introduced by Paolo Calabresi

José Obeso ”Selective vulnerability and the onset and progression of Parkinson’s disease”

11:00 – 12:45 SESSION 4B

Chairpersons: Alessandro Padovani, Fabrizio Stocchi

Antonio Pisani “Impact of genetic animal models to develop new therapeutic strategies in PD”

Paolo Barone “Natural history of non-motor symptoms in Parkinson’s disease”

Fabrizio Stocchi “Early diagnosis for early treatment in Parkinson disease”

12:45 – 13:00 Discussion

13:00 Closing remarks Paolo Calabresi and Lucilla Parnetti

Farewell brunch

SATURDAY 23, MORNING

Page 8: Third Assisi Workshop on Biomarkers in the early diagnosis ... · 16:45 – 17:00 Coffee break 17:00 – 17:45 Magistral Lecture Introduced by Markus Otto Kaj Blennow “CSF biomarkers

SEGRETERIA SCIENTIFICA

Dr. Davide Chiasserini, Dr. Paolo EusebiTel. 075.585.8213 - 585.3545Clinica Neurologica Ospedale Santa Maria della Misericordia - PerugiaE-mails: [email protected] ; [email protected]

SEGRETERIA ORGANIZZATIVA E PROVIDER ECM

CONSULTA UMBRIAVia R. Gallenga, 206127 PerugiaTel. 075 5000066Fax 075 5153466e-mail: [email protected]

SEDE DEL CONVEGNO

Roseo Hotel AssisiVia G. Renzi, 2 - Assisi PG

INFORMATION

Page 9: Third Assisi Workshop on Biomarkers in the early diagnosis ... · 16:45 – 17:00 Coffee break 17:00 – 17:45 Magistral Lecture Introduced by Markus Otto Kaj Blennow “CSF biomarkers

MODALITA’ DI PARTECIPAZIONE

Per partecipare al convegno è necessario collegarsi al sito internet www. consultaumbria.com e compilare il form on-line

• Quota di iscrizione per partecipazione medici residenziali Euro 600,00 (+ iva 22%) comprende : partecipazione ai lavori, kit congressuale, attestato di partecipazione e crediti ECM, due pernottamenti, coffee/breaks e pranzi, come da programma, cene.

• Quota di iscrizione per partecipazione medici locali Euro 350,00 (+ iva 22%)comprende : partecipazione ai lavori, kit congressuale, attestato di partecipazione e crediti ECM coffee/breaks e pranzo come da programma, cena del 22 maggio.

• Quota di iscrizione per partecipazione giovani medici (under 40) Euro 50,00 (+ iva 22%)comprende : partecipazione ai lavori, kit congressuale, attestato di partecipazione e crediti ECM coffee/breaks e pranzo come da programma.

ECML’evento è stato accreditato ECM per le seguenti figure professionali :

• Biologo

• Psicologo • Medico Chirurgo con specializzazione in Neurologia; Neurofisiopatologia; Genetica Medica; Geriatria; Biochimica Clinica; Patologia Clinica (Laboratorio di analisi chimico- cliniche e microbiologia).

Rif. Nr. 124939Crediti Assegnati 17

Page 10: Third Assisi Workshop on Biomarkers in the early diagnosis ... · 16:45 – 17:00 Coffee break 17:00 – 17:45 Magistral Lecture Introduced by Markus Otto Kaj Blennow “CSF biomarkers

NOTE

Page 11: Third Assisi Workshop on Biomarkers in the early diagnosis ... · 16:45 – 17:00 Coffee break 17:00 – 17:45 Magistral Lecture Introduced by Markus Otto Kaj Blennow “CSF biomarkers
Page 12: Third Assisi Workshop on Biomarkers in the early diagnosis ... · 16:45 – 17:00 Coffee break 17:00 – 17:45 Magistral Lecture Introduced by Markus Otto Kaj Blennow “CSF biomarkers

EVENTO REALIZZATO CON IL CONTRIBUTO EDUCAZIONALE NON CONDIZIONANTE DI: